Worldwide cannabis sales are forecast to rise at a blistering compound annual growth rate (CAGR) of 25.5% from 2022 to 2030, according to Grand View Research. Canada's Tilray (NASDAQ: TLRY) is a perfect example of this stark contrast between the industry's stunning growth potential and its outsize risk profile. Tilray's management team is predicting a staggering 69% CAGR in terms of annual sales over the next three years. Read More...
Investor’s Business Daily
Xpeng, China’s EV Startup, Misses On Earnings Amid Economic Uncertainty
Xpeng, the China-based electric-vehicle startup and aspiring Tesla challenger, reported a greater-than-expected loss while narrowly topping revenue expectations Tuesday. While the company’s vehicle deliveries ballooned in July, economic turbulence in China continues to be a concern for XPEV and the broader auto industry. The EV manufacturer has its operations in China, with offices in Mountain View, Calif. Since going public in 2020, it has weathered a struggling economy, Covid lockdowns, government crackdowns on tech companies and recent power restrictions in key provinces.
Add Comment